肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

蒽环类药物心脏毒性保护剂临床应用的热点问题

2011-11-13 MedSci原创 MedSci原创

蒽环类乳腺癌心脏毒性
关注

蒽环类药物心脏毒性保护剂临床应用的热点问题

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1835548, encodeId=8c5a183554897, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon May 28 01:05:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957042, encodeId=6255195e04246, content=<a href='/topic/show?id=c1b16e228bc' target=_blank style='color:#2F92EE;'>#热点问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67228, encryptionId=c1b16e228bc, topicName=热点问题)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Mar 06 02:05:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418104, encodeId=93ae1418104ad, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521680, encodeId=56081521680ca, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2012-05-28 clmlylxy

    #临床应用#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1835548, encodeId=8c5a183554897, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon May 28 01:05:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957042, encodeId=6255195e04246, content=<a href='/topic/show?id=c1b16e228bc' target=_blank style='color:#2F92EE;'>#热点问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67228, encryptionId=c1b16e228bc, topicName=热点问题)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Mar 06 02:05:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418104, encodeId=93ae1418104ad, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521680, encodeId=56081521680ca, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2012-03-06 小几洁

    #热点问题#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1835548, encodeId=8c5a183554897, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon May 28 01:05:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957042, encodeId=6255195e04246, content=<a href='/topic/show?id=c1b16e228bc' target=_blank style='color:#2F92EE;'>#热点问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67228, encryptionId=c1b16e228bc, topicName=热点问题)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Mar 06 02:05:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418104, encodeId=93ae1418104ad, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521680, encodeId=56081521680ca, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2011-11-14 智慧医人

    #蒽环类药物#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1835548, encodeId=8c5a183554897, content=<a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22789, encryptionId=cfdc22e893f, topicName=临床应用)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc8528, createdName=clmlylxy, createdTime=Mon May 28 01:05:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957042, encodeId=6255195e04246, content=<a href='/topic/show?id=c1b16e228bc' target=_blank style='color:#2F92EE;'>#热点问题#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67228, encryptionId=c1b16e228bc, topicName=热点问题)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Tue Mar 06 02:05:00 CST 2012, time=2012-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1418104, encodeId=93ae1418104ad, content=<a href='/topic/show?id=3caf8834200' target=_blank style='color:#2F92EE;'>#蒽环类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88342, encryptionId=3caf8834200, topicName=蒽环类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智慧医人, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521680, encodeId=56081521680ca, content=<a href='/topic/show?id=a59d88340d2' target=_blank style='color:#2F92EE;'>#蒽环类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88340, encryptionId=a59d88340d2, topicName=蒽环类)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97d111387900, createdName=shijzhiewnjhch, createdTime=Mon Nov 14 15:05:00 CST 2011, time=2011-11-14, status=1, ipAttribution=)]
    2011-11-14 shijzhiewnjhch

    #蒽环类#

    0